Semenogelin I (SEMG1) (Middle Region) Peptide
SEMG1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all SEMG1 products
- SEMG1 (Semenogelin I (SEMG1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SEMG1 antibody (Catalog #: ARP42089_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SEMG1 (Semenogelin I (SEMG1))
- Background
-
SEMG1 is the predominant protein in semen. The secreted protein is involved in the formation of a gel matrix that encases ejaculated spermatozoa. The prostate-specific antigen (PSA) protease processes this protein into smaller peptides, with each possibly
Alias Symbols: MGC14719, SEMG, SGI, CT103, dJ172H20.2
Protein Interaction Partner: KLK2,KLK3,PRKCA,SEMG2,TGM1,UBQLN4,SEMG2
Protein Size: 402 - Molecular Weight
- 40 kDa
- Gene ID
- 6406
- NCBI Accession
- NM_198139, NP_937782
-
You are here:
